These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


388 related items for PubMed ID: 11896504

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ, Taylor KP, Ashby MJ, Brown MJ.
    Circulation; 2007 Jul 17; 116(3):268-75. PubMed ID: 17606839
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Primary aldosteronism: A common and curable form of hypertension.
    Young WF.
    Cardiol Rev; 1999 Jul 17; 7(4):207-14. PubMed ID: 10423672
    [Abstract] [Full Text] [Related]

  • 8. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity.
    Lim PO, Jung RT, MacDonald TM.
    J Hum Hypertens; 2002 Mar 17; 16(3):153-8. PubMed ID: 11896503
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recent advances in diagnosis and treatment of primary aldosteronism.
    Veglio F, Morello F, Rabbia F, Leotta G, Mulatero P.
    Minerva Med; 2003 Aug 17; 94(4):259-65. PubMed ID: 14605590
    [Abstract] [Full Text] [Related]

  • 11. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M, Zosin I, Maser-Gluth C, Hermsen D, Cupisti K, Schott M, Schinner S, Knoefel WT, Scherbaum WA, Willenberg HS.
    Hypertens Res; 2010 Aug 17; 33(8):850-6. PubMed ID: 20520614
    [Abstract] [Full Text] [Related]

  • 12. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S, Seifarth C, Schobel H, Hahn EG, Hensen J.
    Exp Clin Endocrinol Diabetes; 2002 Apr 17; 110(2):80-5. PubMed ID: 11928071
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A, Postuła M, Cybulska I, Dobrucki T, Kabat M, Peczkowska M, Janas J, Janaszek-Sitkowska H, Makowiecka-Cieśla M, Januszkiewicz A.
    Kardiol Pol; 2003 Jan 17; 58(1):17-26. PubMed ID: 14502298
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL, Opie LH, Davidson JS.
    S Afr Med J; 2000 Apr 17; 90(4):394-400. PubMed ID: 10957926
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Primary hyperaldosteronism.
    Nadar S, Lip GY, Beevers DG.
    Ann Clin Biochem; 2003 Sep 17; 40(Pt 5):439-52. PubMed ID: 14503982
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.